Whereas inhibition of p53 in fibroblasts promotes a CAF phenotype, inhibition of another tumor suppressor, breast cancer type 1 susceptibility protein (BRCA1), allows cancer cell-derived EVs to promote an oncogenic phenotype in recipient fibroblasts that is similar to that of the inducing cancer cells [117,118,119]. The gene discussed is BRCA1; the disease is cancer.